Adrian Gropper, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 52 Marshall St, Watertown, MA 02472 Phone: 617-395-6744 |
News Archive
How your carotid artery moves can reveal your risk of a future heart attack, and it is now possible to study this vessel aspect in more detail thanks to a new technique which could eventually be used to identify patients with suspected coronary artery disease, reveals a thesis from the University of Gothenburg, Sweden.
Genentech has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Avastin (bevacizumab) as a therapy for people with previously treated glioblastoma. If accepted by the FDA, the application would be considered for an accelerated approval that allows provisional approval of medicines for cancer or other life-threatening diseases based on preliminary evidence suggesting clinical benefit.
Secretary of State Hillary Rodham Clinton spoke about President Barack Obama's $63 billion Global Health Initiative (GHI) during a speech on Monday at Johns Hopkins School of Advanced International Studies, Reuters' "Front Row Washington" blog reports (Ashburn, 8/16).
PDL BioPharma, Inc. announced today it has received a facsimile letter from Genentech asserting that Avastin, Herceptin, Lucentis and Xolair (the Genentech Products) do not infringe supplementary protection certificates granted by various countries in Europe to PDL and is seeking a response from PDL to these assertions.
› Verified 5 days ago